Risk factors for primary open angle glaucoma progression: What we know and what we need to know

Current Opinion in Ophthalmology

Volumn 19, Issue 2, 2008, Pages 102-106

  Rivera, Jorge L ^a   Bell, Nicholas P ^a   Feldman, Robert M ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Robert Cizik Eye Clinic   (United States)

Author keywords

Blindness; Open angle glaucoma; Progression; Risk factors

Indexed keywords

BLINDNESS; CARDIOVASCULAR DISEASE; CORNEA THICKNESS; DISEASE ASSOCIATION; DISEASE COURSE; HEREDITY; HUMAN; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VISUAL IMPAIRMENT;

DISEASE PROGRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; RISK FACTORS;

EID: 40049084357     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282f493b3     Document Type: Review

References (43)

1. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977; 106:17-32.
2. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991; 134:1102-1110.
3. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992; 99:1499-1504.
4. Rodriguez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 2002; 109:737-743.
5. Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998; 105:2099-2104.
6. Schoff EO, Hattenhauer MG, Ing HH, et al. Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology 2001; 108:882-886.
7. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994; 112:821-829.
8. National Eye Institute/Prevent Blindness America. Vision problems in the U.S.: prevalence of adult vision impairment and age-related eye disease in America. 4th ed. Chicago: Prevent Blindness America; 2002.
9. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989; 96:1363-1368.
10. Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands The Rotterdam Study. Ophthalmology 1994; 101:1851-1855.
11. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996; 103:1661-1669.
12. Wensor MD, McCarty CA, Stanislavsky YL, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998; 105:733-739.
13. Chen PP. Blindness in patients with treated open angle glaucoma. Ophthalmology 2003; 110:726-733.
14. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-393.
15. Kwon YH, Kim CS, Zimmerman MB, et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 2001; 132:47-56.
16. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996; 103:1721-1726.
17. Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol 1996; 122:355-363.
18. Rasker MT, van den Enden A, Bakker D, Hoyng PF. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol 2000; 118:481-488.
19. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999; 106:2144-2153.
20. Oliver JE, Hattenhauer MG, Herman D, et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002; 133:764-772.
21. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114:1965-1972. This paper presents the final EMGT dataset. It provides updated information regarding progression related factors with a longer follow-up time. It confirms the importance of previously reported factors and also identifies new predictive factors to consider.
22. Bengtsson B, Leske MC, Hyman L, Heijl A. Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114:205-209. This report examines the relationship between IOP fluctuation and glaucoma progression in a cohort of patients from the EMGT.
23. Lazaro C, Garcia-Feijoo J, Castillo A, et al. Impact of intraocular pressure after filtration surgery on visual field progression in primary open-angle glaucoma. Eur J Ophthalmol 2007; 17:357-362.
24. Lee PP, Walt JW, Rosenblatt LC, et al. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol 2007; 144:901-907.
25. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol 2007; 125:1010-1013.
26. Kiuchi T, Motoyama Y, Oshika T. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma. Ophthalmology 2006; 113:2150-2155.
27. Siam GA, de Barros DS, Gheith ME, et al. The amount of intraocular pressure rise during pharmacological pupillary dilatation is an indicator of the likelihood of future progression of glaucoma. Br J Ophthalmol 2007; 91:1170-1172.
28. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001; 108:1779-1788.
29. Congdon NG, Broman AT, Bandeen-Roche K, et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 2006; 141:868-875.
30. Balaratnasingam C, Morgan WH, Hazelton ML, et al. Value of retinal vein pulsation characteristics in predicting increased optic disc excavation. Br J Ophthalmol 2007; 91:441-444.
31. Shah H, Kniestedt C, Bostrom A, et al. Role of central corneal thickness on baseline parameters and progression of visual fields in open angle glaucoma. Eur J Ophthalmol 2007; 17:545-549.
32. Weizer JS, Stinnett SS, Herndon LW. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol 2006; 90:732-736.
33. Jonas JB, Stroux A, Martus P, Budde W. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage. J Glaucoma 2006; 15:206-212.
34. Suzuki Y, Iwase A, Araie M, et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology 2006; 113:1613-1617. This large population-based study examined the relationship of several risk factors such as IOP, myopia and age and open angle glaucoma.
35. Xu L, Wang Y, Wang S, et al. High myopia and glaucoma susceptibility the Beijing Eye Study. Ophthalmology 2007; 114:216-220.
36. Perdicchi A, Iester M, Scuderi G, et al. Visual field damage and progression in glaucomatous myopic eyes. Eur J Ophthalmol 2007; 17:534-537.
37. Kim SH, Park KH. The relationship between recurrent optic disc hemorrhage and glaucoma progression. Ophthalmology 2006; 113:598-602.
38. Zeitz O, Galambos P, Wagenfeld L, et al. Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol 2006; 90:1245-1248.
39. Plange N, Kaup M, Arend O, Remky A. Asymmetric visual field loss and retrobulbar haemodynamics in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2006; 244:978-983.
40. Mabuchi F, Tang S, Kashiwagi K, et al. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol 2007; 143:125-130. This paper identifies the role of the OPA1 gene in patients with normal tension and high-tension glaucoma. It emphasizes the importance of genetics in our understanding of the disease.
41. Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006; 47:2533-2541. This paper identifies several mitochondrial abnormalities in patients with POAG. It suggests that oxidative stress and mitochondrial dysfunction may be risk factors for glaucoma.
42. Nolan MJ, Giovingo MC, Miller AM, et al. Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma. J Glaucoma 2007; 16:419-429.
43. Wu J, Hewitt AW, Green CM, et al. Disease severity of familial glaucoma compared with sporadic glaucoma. Arch Ophthalmol 2006; 124:950-954.